Search the Newsreel

Lindsay Corp (LNN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Lindsay Corp (LNN), detailing its current price momentum score, support and resistance levels. It includes a breakdown of various technical indicators like MACD, RSI, and moving averages, offering insights into buy, sell, or neutral signals for the …

ADAR1 Capital Management LLC Has $2.47 Million Stock Position in Bright Minds Biosciences Inc. $DRUG

ADAR1 Capital Management LLC significantly increased its stake in Bright Minds Biosciences Inc. (NASDAQ:DRUG) by 868.6% in the first quarter, now holding 33,900 shares valued at $2.47 million. Institutional investors collectively own 40.52% of the company, which reported a narrower-than-expected quarterly loss of $0.80 …

Bright Minds Biosciences Market Sentiment

This article analyzes Bright Minds Biosciences (DRUG) market sentiment based on analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" consensus from 10 analysts with an average price target of $128, a 12.6% short float, and provides a detailed history …

Happiest Minds Q1 Results: Profit rises 18% YoY to Rs 68 crore; revenue up 14%

Happiest Minds Technologies Limited Provides Earnings Guidance for the Fiscal Year 2027

HAPPSTMNDS: Q1 FY27 delivered strong revenue and profit growth, driven by AI and digital services

Stocks to watch, July 28: Coforge, Happiest Minds, HUL, Coal India, HDFC Bank, IndiGo, Tata Power, L&T

LNN|Lindsay Corp|Price:117.010|Chg%:+2.410

This article provides a comprehensive stock analysis of Lindsay Corp (LNN), highlighting its healthy fundamentals and significant growth potential. The company is considered fairly valued within its industry, boasts high institutional ownership, and has received "Buy" ratings from analysts with a target price of …

Price-Driven Insight from (LNN) for Rule-Based Strategy

This article provides a price-driven analysis for Lindsay Corporation (LNN), highlighting a positive near-term sentiment with a potential shift and a mid-channel oscillation pattern. It outlines an exceptional 39.7:1 risk-reward setup, indicating a target gain of 11.5% versus a 0.3% risk. The analysis also …

Bright Minds Biosciences Inc

DRUG|Bright Minds Biosciences Inc|Price:70.680|Chg%:-1.280

This article provides an analysis of Bright Minds Biosciences Inc. (DRUG) through TradingKey's stock score system. It details the methodologies used to generate scores across various dimensions including financial health, valuation, earnings forecasts, price momentum, institutional confidence, and risk management. However, it explicitly states …

Bright Minds Biosciences Inc (DRUG) Cash Flow

This article provides a detailed cash flow statement for Bright Minds Biosciences Inc (DRUG), covering operating, investing, and financing activities on a quarterly and annual basis. It presents extensive historical financial data, including net income, changes in working capital, and various components of cash …

LNN|Lindsay Corp|Price:113.910|Chg%:-0.050

This article provides a detailed company profile of Lindsay Corp (LNN), a global manufacturer and distributor of irrigation and infrastructure equipment. It outlines the company's business segments, key products, financial data including market capitalization and P/E ratio, and lists its executive team and their …

Lindsay Corp (LNN) Income Statement

This article presents the quarterly and annual income statements for Lindsay Corp (LNN) from FY2012Q1 to FY2026Q3, allowing users to analyze the company's financial performance and operational efficiency. It details various financial metrics such as total revenue, cost of revenue, operating expenses, operating profit, …

40,000 Shares in Bright Minds Biosciences Inc. $DRUG Acquired by Orbimed Advisors LLC

Orbimed Advisors LLC acquired 40,000 shares of Bright Minds Biosciences Inc. (NASDAQ:DRUG), a stake valued at approximately $2.9 million, contributing to institutional investors' 40.52% ownership. Analysts maintain a "Buy" rating with an average target price of $143.83, some raising targets and Zacks upgrading the …

Happiest Minds Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Bright Minds Biosciences Inc (DRUG) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Bright Minds Biosciences Inc (DRUG). It lists the top institutional shareholders, their shareholdings, and the percentage change in their positions. The company's stock information, including market cap and recent price movements, is also provided.

Lindsay Corp (LNN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of Lindsay Corp's (LNN) dividend payouts and stock split events, detailing past and upcoming dividend distributions. It lists the dividend amount, record date, payment date, and ex-dividend date for various interim and final cash dividends. Over the past …

Lindsay Corp (LNN) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Lindsay Corp (LNN), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 4 analysts, the consensus is a "Buy" with an average target price of $127.00. The report also includes FAQs about …

Lindsay Corp (LNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Lindsay Corp (LNN), focusing on its regional revenue contributions. As of FY2026Q2, North America contributed $71.04 million (45.04%) and International segments contributed $70.20 million (44.51%) to the company's revenue. The article notes that detailed data for business …

Happiest Minds Shares Advance 1.86% as Company Sets Tomorrow as Ex-Date for Dividend Post-AGM

Lindsay Corp (LNN) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Lindsay Corp (LNN), highlighting its major institutional holders and their proportion of shares. Key shareholders include BlackRock Institutional Trust Company, N.A., Neuberger Berman, LLC, and various Vanguard entities. The article also provides historical institutional shareholding data and …

Lindsay Corporation Revenue Breakdown – SWB:LMF

Lindsay Corporation (SWB:LMF) generated €578.95 million in revenue last year. The majority of this, €486.19 million, came from its Irrigation segment, an increase from the previous year. The United States was the largest geographical contributor, accounting for €299.79 million of the revenue.

Lindsay Corporation (LNN) Stock Forecasts

Argus has lowered its price target for Lindsay Corporation (LNN) to $106.00, down from its previous target. Lindsay Corp is a company that specializes in proprietary water management and road infrastructure products and services, particularly known for manufacturing and distributing agricultural irrigation equipment. The …

Walleye Capital LLC Has $3.92 Million Holdings in Bright Minds Biosciences Inc. $DRUG

Walleye Capital LLC significantly increased its stake in Bright Minds Biosciences Inc. (NASDAQ:DRUG) by 108% in the first quarter, now holding 53,706 shares valued at $3.92 million. Other institutional investors also boosted their positions, with hedge funds and institutions collectively owning 40.52% of the …

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Zacks Research

Zacks Research has upgraded Bright Minds Biosciences (NASDAQ:DRUG) from "hold" to "strong-buy," contributing to a consensus "Buy" rating among analysts with a target price of $143.83. This upgrade follows the company's recent strong quarterly earnings report, where its EPS of ($0.80) surpassed estimates of …

Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?

All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy

How Investors Are Reacting To Lindsay (LNN) CFO Transition And Dividend Increase

Lindsay Corporation announced the resignation of its CFO, Sam Hinrichsen, effective August 31, 2026, and simultaneously increased its quarterly dividend to US$0.38 per share. This move signals management's confidence despite a period of softer sales, influencing the investment narrative around balancing growth investment with …

Lindsay Corp's Sam Hinrichsen To Resign As CFO Effective August 31, 2026 - SEC Filing

Lindsay Corp (NYSE: LNN) announced that its Chief Financial Officer, Sam Hinrichsen, will resign from his position effective August 31, 2026. This information was disclosed in a recent SEC filing. No further details regarding the reason for his resignation or a successor were provided …

Lindsay Corporation Announces Resignation of Sam Hinrichsen from Chief Financial Officer, Effective August 31, 2026

Lindsay Corporation announced the resignation of Sam Hinrichsen from his position as Senior Vice President and Chief Financial Officer, effective August 31, 2026. The resignation is for personal reasons and is not related to any disagreements with the company's operations, policies, or accounting practices. …

Lindsay Corporation (NYSE: LNN) CFO to resign, signs paid transition agreement

Lindsay Corporation announced that its Senior Vice President and CFO, Sam Hinrichsen, will resign effective August 31, 2026, for personal reasons. He will provide transition services until December 31, 2026, under a Transition Services Agreement, receiving $100,000 for services, a 2026 annual bonus, and …

Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 5% - Should You Buy?

Bright Minds Biosciences (NASDAQ:DRUG) shares increased by 5% on Friday, reaching $79.16 with below-average trading volume. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $143.83, and recently surpassed EPS estimates. Insider and institutional ownership remains significant, …

(LNN) Price Dynamics and Execution-Aware Positioning

This article analyzes Lindsay Corporation (LNN) using AI models to provide insights into its price dynamics and positioning. Key findings include a strong near-term sentiment potentially challenging long-term weakness, an exceptional risk-reward setup targeting an 11.7% gain, and detailed trading strategies for various risk …

Is Lindsay Australia (ASX: LAU) an Underrated Transport Stock to Watch?

Results: Lindsay Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts